Zotefoams plc (LON:ZTF - Get Free Report) insider Gary McGrath bought 50 shares of Zotefoams stock in a transaction dated Tuesday, February 11th. The stock was acquired at an average cost of GBX 299 ($3.72) per share, with a total value of £149.50 ($186.08).
Gary McGrath also recently made the following trade(s):
- On Wednesday, December 11th, Gary McGrath purchased 44 shares of Zotefoams stock. The stock was bought at an average price of GBX 343 ($4.27) per share, with a total value of £150.92 ($187.85).
Zotefoams Price Performance
Zotefoams stock opened at GBX 305 ($3.80) on Thursday. The firm has a market cap of £148.23 million, a PE ratio of 1,525.00, a price-to-earnings-growth ratio of 0.66 and a beta of 1.40. The company has a debt-to-equity ratio of 43.67, a current ratio of 1.30 and a quick ratio of 0.67. The stock's fifty day moving average price is GBX 311.56 and its two-hundred day moving average price is GBX 379.30. Zotefoams plc has a one year low of GBX 279.73 ($3.48) and a one year high of GBX 595.20 ($7.41).
Zotefoams Company Profile
(
Get Free Report)
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
